 |
|
|
|||||
Early Q1 results reveal a slowdown in revenue and profit growth, hitting a nine-quarter low, excluding Reliance Industries' one-time gain. Banking, finance, FMCG, and IT sectors are showing lackluster performance, impacting overall growth. While initial expectations were high for sectors like capital goods and healthcare, the current trend indicates a weaker earnings picture.
Category:
News and Media
Foreign investors are showing caution towards the Indian stock market. Derivative bets indicate a bearish outlook. Uncertainties surrounding global trade tariffs are a major concern. Muted quarterly results also contribute to the negative sentiment. The long-short ratio, a key market indicator, has fallen significantly. This reflects increased short positions by foreign institutional investors.
Category:
News and Media
The Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, fashion and industrials. The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices. Shanghai Fosun Pharmaceutical Co. had acquired an 86% stake in Gland Pharma in 2016 from KKR for a record deal value of $1.26 billion.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||